Histologic Assessment of Non–Small Cell Lung Carcinoma after Neoadjuvant Therapy
Open Access
- 1 November 2003
- journal article
- research article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 16 (11), 1102-1108
- https://doi.org/10.1097/01.mp.0000096041.13859.ab
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Dose-response relationship between probability of pathologic tumor control and glucose metabolic rate measured with FDG PET after preoperative chemoradiotherapy in locally advanced non-small-cell lung cancerInternational Journal of Radiation Oncology*Biology*Physics, 2002
- Grading of Tumor Regression in Non-small Cell Lung CancerChest, 2001
- Induction chemotherapy before surgery for early-stage lung cancer: A novel approachThe Journal of Thoracic and Cardiovascular Surgery, 2000
- Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trialLung Cancer, 1999
- Comparison of Computed Tomography and Pathologic Examination for Evaluation of Response of Primary Lung Cancer to Neoadjuvant TherapyJournal of Thoracic Imaging, 1999
- Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancerLung Cancer, 1998
- Tumour regression in non-small-cell lung cancer following neoadjuvant therapy. Histological assessmentZeitschrift für Krebsforschung und Klinische Onkologie, 1997
- Histologic changes in small cell lung carcinoma after treatmentCancer, 1996
- A Randomized Trial Comparing Perioperative Chemotherapy and Surgery With Surgery Alone in Resectable Stage IIIA Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1994
- Postoperative complications after combined neoadjuvant treatment of lung cancerThe Annals of Thoracic Surgery, 1993